138 related articles for article (PubMed ID: 37430049)
1. Discrimination of Multidrug Resistance in Cancer Cells Achieved Using Single-Cell Analysis.
Wang H; Zhang R; Yang D; Wang X
Methods Mol Biol; 2023; 2689():95-106. PubMed ID: 37430049
[TBL] [Abstract][Full Text] [Related]
2. The microfluidic capture of single breast cancer cells for multi-drug resistance assays.
Parekh K; Sharifi H; Khamenehfar A; Beischlag TV; Payer RTM; Li PCH
Methods Enzymol; 2019; 628():113-127. PubMed ID: 31668225
[TBL] [Abstract][Full Text] [Related]
3. Dielectrophoretic trapping of single leukemic cells using the conventional and compact optical measurement systems.
Sharifi Noghabi H; Soo M; Khamenehfar A; Li PCH
Electrophoresis; 2019 May; 40(10):1478-1485. PubMed ID: 30701577
[TBL] [Abstract][Full Text] [Related]
4. A simple and fast microfluidic approach of same-single-cell analysis (SASCA) for the study of multidrug resistance modulation in cancer cells.
Li X; Chen Y; Li PC
Lab Chip; 2011 Apr; 11(7):1378-84. PubMed ID: 21327253
[TBL] [Abstract][Full Text] [Related]
5. Dielectrophoretic Microfluidic Chip Enables Single-Cell Measurements for Multidrug Resistance in Heterogeneous Acute Myeloid Leukemia Patient Samples.
Khamenehfar A; Gandhi MK; Chen Y; Hogge DE; Li PC
Anal Chem; 2016 Jun; 88(11):5680-8. PubMed ID: 27149245
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of idarubicin, daunorubicin, and their C-13 alcohol metabolites to transport-mediated multidrug resistance.
Ross DD; Doyle LA; Yang W; Tong Y; Cornblatt B
Biochem Pharmacol; 1995 Nov; 50(10):1673-83. PubMed ID: 7503771
[TBL] [Abstract][Full Text] [Related]
7. Same-single-cell analysis for the study of drug efflux modulation of multidrug resistant cells using a microfluidic chip.
Li X; Ling V; Li PC
Anal Chem; 2008 Jun; 80(11):4095-102. PubMed ID: 18447319
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of daunorubicin accumulation, retention, and cytotoxicity by verapamil or cyclosporin A in blast cells from patients with previously untreated acute myeloid leukemia.
Ross DD; Wooten PJ; Sridhara R; Ordóñez JV; Lee EJ; Schiffer CA
Blood; 1993 Aug; 82(4):1288-99. PubMed ID: 8102561
[TBL] [Abstract][Full Text] [Related]
9. Synergistic reversal of multidrug-resistance phenotype in acute myeloid leukemia cells by cyclosporin A and cremophor EL.
Ross DD; Wooten PJ; Tong Y; Cornblatt B; Levy C; Sridhara R; Lee EJ; Schiffer CA
Blood; 1994 Mar; 83(5):1337-47. PubMed ID: 8118035
[TBL] [Abstract][Full Text] [Related]
10. Same-single-cell analysis using the microfluidic biochip to reveal drug accumulation enhancement by an amphiphilic diblock copolymer drug formulation.
Khamenehfar A; Wan CP; Li PC; Letchford K; Burt HM
Anal Bioanal Chem; 2014 Nov; 406(28):7071-83. PubMed ID: 25315452
[TBL] [Abstract][Full Text] [Related]
11. In vitro effect of multidrug resistance modifiers on idarubicinol efflux in blasts of acute myeloid leukemia.
Schröder JK; Kasimir-Bauer S; Seeber S; Scheulen ME
J Cancer Res Clin Oncol; 2000 Feb; 126(2):111-6. PubMed ID: 10664252
[TBL] [Abstract][Full Text] [Related]
12. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells.
Liu ZL; Hirano T; Tanaka S; Onda K; Oka K
J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364
[TBL] [Abstract][Full Text] [Related]
13. Multidrug resistance-modifying components in human plasma with potential clinical significance.
Mülder HS; Pinedo HM; Timmer AT; Rao BR; Lankelma J
J Exp Ther Oncol; 1996 Jan; 1(1):13-22. PubMed ID: 9414384
[TBL] [Abstract][Full Text] [Related]
14. Lipid raft modulation by Rp1 reverses multidrug resistance via inactivating MDR-1 and Src inhibition.
Yun UJ; Lee JH; Koo KH; Ye SK; Kim SY; Lee CH; Kim YN
Biochem Pharmacol; 2013 May; 85(10):1441-53. PubMed ID: 23473805
[TBL] [Abstract][Full Text] [Related]
15. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
16. Regulation of cellular glutathione modulates nuclear accumulation of daunorubicin in human MCF7 cells overexpressing multidrug resistance associated protein.
Benderra Z; Trussardi A; Morjani H; Villa AM; Doglia SM; Manfait M
Eur J Cancer; 2000 Feb; 36(3):428-34. PubMed ID: 10708946
[TBL] [Abstract][Full Text] [Related]
17. Single-cell-kinetics approach to compare multidrug resistance-associated membrane transport in subpopulations of cells.
Koshkin V; Krylov SN
Anal Chem; 2011 Aug; 83(16):6132-4. PubMed ID: 21770449
[TBL] [Abstract][Full Text] [Related]
18. Probenecid reverses multidrug resistance in multidrug resistance-associated protein-overexpressing HL60/AR and H69/AR cells but not in P-glycoprotein-overexpressing HL60/Tax and P388/ADR cells.
Gollapudi S; Kim CH; Tran BN; Sangha S; Gupta S
Cancer Chemother Pharmacol; 1997; 40(2):150-8. PubMed ID: 9182837
[TBL] [Abstract][Full Text] [Related]
19. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line.
Li J; Xu LZ; He KL; Guo WJ; Zheng YH; Xia P; Chen Y
Breast Cancer Res; 2001; 3(4):253-63. PubMed ID: 11434876
[TBL] [Abstract][Full Text] [Related]
20. [The relationship between multi-drug resistance gene expression and drug resistance of ovarian carcinoma].
Zhu L; Lang J; Shen K
Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):462-6. PubMed ID: 9639738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
